Novel PDE-delta inhibitor disrupts its interaction with mutant KRAS and inhibits tumor growth Oct. 2, 2019
NantKwest studies PD-L1 t-haNK for locally advanced or metastatic solid cancers in phase I Oct. 1, 2019
RSS